Background: Medication errors are a leading cause of harm to patients in hospital that can be decreased by electronic medication management systems. Aims: This study determined the effects of electronic prescribing using the Enterprise Patient Administration System (EPAS) on prescribing errors and adverse drug reaction (ADR) documentation in South Australian public hospitals. Methods: A prospective structured medication chart audit was conducted before (in 2012) and after the implementation (in Dec 2014) of EPAS, comparing the paper-based National Inpatient Medication Chart (NIMC) with prescribing. All inpatients were eligible for inclusion in the study. Prescribing order errors were determined by the percentage of medication orders that had unclear, illegal or unsafe prescriptions. The quality of ADR documentation was assessed by the percentage of patients with correct documentation. Results: The total number of prescribing errors before and after the implementation of EPAS was 67.7 and 2.8 per 100 orders, respectively. The frequency of prescribing order errors due to unclear, illegal and unsafe prescriptions decreased to almost zero with EPAS. Prescriptions classified as unsafe due to incorrect dose, route of administration or dosing frequency decreased from 5.8% to 0.03% of medication orders before versus after EPAS implementation (p < 0.0001). Completed ADR documentation was similar between the paper-based NIMC and EPAS, but the percentage of patients with ADR alerts who required them was 100% in EPAS compared with 27% on the NIMC (p < 0.0001).
INTRODUCTION
Medication errors are a leading cause of harm to patients in hospital. 1 There are many sources of error in the medication management cycle, from history taking to dose administration and the monitoring of response, but prescribing errors are potentially the most serious. 2 Prescribing errors with paper-based systems in Australian hospitals occur at a rate of approximately five per patient, predominantly from procedural errors such as unclear orders and clinical errors such as incorrect dose contributing at a rate of 0.2 per patient. [3] [4] [5] Two major approaches to address prescribing errors in Australian hospitals have been implemented over the past 10-15 years, namely the National Inpatient Medication Chart (NIMC) 6 and electronic medication management systems (e-prescribing). Introduction of the standardised NIMC decreased prescribing errors between 5% and 15% of medication orders per patient. 3, 7 Recent evidence suggests that the positive effect of e-prescribing may be greater, with decreases in prescribing errors of 50% or greater compared with paper-based systems. 4, 5, 8 These Australian studies agree with the international data that support the effectiveness of standardised medication charts and e-prescribing in decreasing the frequency of prescribing errors in hospital. 9, 10 The Enterprise Patient Administration System (EPAS) is an electronic health record with e-prescribing functionality that is currently being implemented in South Australian (SA) public hospitals. It is a modified version of the Allscripts Sunrise product (Allscripts, Chicago, IL, USA) that includes clinical documentation, results management, clinician order entry and electronic medication prescribing and administration. The transition from paper-based prescribing to EPAS has caused concern among some local healthcare professionals about the potential for increased medication errors, due primarily to new prescribing and dose administration processes.
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The NIMC audit tool, developed by the Australian Commission on Safety and Quality in Health Care, 12 is used in Australian hospitals at regular intervals to evaluate the safety and quality of prescribing and medication chart documentation, and has recently been applied to e-prescribing. 13 The presence of baseline NIMC audit data and methodology provided an opportunity to objectively evaluate the safety of paper-based prescribing versus e-prescribing using EPAS. The hypothesis of the present study using the NIMC audit methodology was that e-prescribing would decrease prescribing errors in SA public hospitals compared with the NIMC.
METHODS
The study was conducted at three public hospitals where EPAS e-prescribing had been implemented, namely Noarlunga Health Service (a small peripheral community hospital), The Repatriation General Hospital (a general metropolitan hospital) and the Port Augusta Health Service (a general rural hospital). The present study was a before and after study comparing prescribing errors before and after e-prescribing implementation using a modification of the NIMC audit methodology for e-prescribing. Some audit questions did not apply to the e-prescribing interface, such as the number of medication charts, the presence of warfarin guidelines at the end of the patient's bed or with medication chart, and the number of sustained-release (SR) medications with the SR box ticked. The audit extended to all medications that would be prescribed on an NIMC chart, including regular medications, warfarin and variable, stat and as required medications. We did not include continuous infusions or chemotherapy. Two clinicians (FA and SS) reviewed the first 20 cases individually and compared outcomes. Because there was a very high degree of agreement, one author (FA) conducted the remainder of the audit. In both the paper and the EPAS audits, a random selection of patients was chosen across all units of the hospitals. In the EPAS audit, one of the hospitals was oversampled so that the sample size of each hospital would not deidentify the results. Because NIMC audits are routinely performed for quality assurance purposes, ethics approval was not required.
The baseline audit used the data collected using standard NIMC audit methodology in August-September 2012. The EPAS audit was collected in December 2014 using Auditmaker (auditmaker.net, accessed 09 January 2015).
The different prescribing errors were classified as follows:
• Unclear prescription orders where there was any illegibility or ambiguity in the prescription and potential for increased risk of patient harm, including: unclear name, dose, route or frequency of administration; the use of error-prone abbreviations (e.g. q2h); where the prescription frequency did not match the marked administration times (e.g. four times a day dosing said to be given at 0800, 1200 and 1600 hours); where the SR box was not ticked for such a formulation on the NIMC; or the immediate release formulation was selected in e-prescribing.
• Illegal prescription orders where there is insufficient information on the prescription for it to be a legally valid prescription (e.g. missing dose, route, frequency or signature of prescriber).
• Unsafe prescription orders where the information was incorrect with regard to dose, route or frequency (e.g. gentamicin subcutaneously, oral insulin).
Statistical analyses were conducted with Fisher's exact tests used to compare proportions before and after EPAS implementation, with two-sided p < 0.05 considered significant.
RESULTS

Medication Order and Patient Information
In all, 100 patients (1145 medication orders) were audited before EPAS (NIMC) and 243 patients (3544 medication orders) were audited after EPAS (Table 1) . There were slight differences in the distribution of the types of medication orders between the different audits, with fewer warfarin and intermittent orders in the EPAS audit. Only 38% of patients had complete identification on all pages of the NIMC compared with 100% in EPAS (p < 0.0001).
Prescribing Errors
There were 776 prescribing errors in 1145 medication orders (67.7 errors per 100 orders) before EPAS with paper prescribing, compared with 101 errors in 3544 medication orders after EPAS with e-prescribing (2.8 errors per 100 medication orders; p < 0.0001). The percentage of prescriptions with order errors according to the classifications of unclear, illegal and unsafe prescriptions is given in Table 2 . Implementation of e-prescribing eliminated prescribing order errors due to unclear prescriptions; in addition, information regarding drug and prescriber name, dose, route of administration and dosing frequency were clear in almost 100% of medication orders. Importantly, the frequency of prescribing order errors due to illegal prescriptions was decreased to almost zero using EPAS.
Prescription orders that were classified as unsafe due to incorrect dose, route of administration or dosing frequency decreased from a total of 5.8% to 0.03% of medication orders before versus after the implementation of EPAS (p < 0.0001). The introduction of EPAS increased the prescribing of duplicate medications with the potential to cause harm (from 6% to 13%), although this change was not statistically significant (p = 0.0594). Figure 1 compares the pre-and post-EPAS audits of ADR documentation. The percentage of patients with a documented ADR (included in patient records either from previous admission or medical history) was similar between the audits (~35%), but there was a greater number of patients in the post-EPAS period with completed ADR documentation (i.e. including documentation of 'nil known' or 'unknown' ADR documentation; 94% vs 84% in the pre-vs post-EPAS periods, respectively; p = 0.0064). In patients with a previously documented ADR, the percentage with an alert sticker in place in paper prescribing was very low (27%) compared with the presence of an alert on all ordering screens in e-prescribing (100%; p < 0.0001). The number of patients with a known ADR having re-exposure to a drug of the same class was similar, but with electronic documentation there was documentation of the reason in the alert acknowledgement field.
ADR Documentation
Other Medication-Related Factors
The number of omitted medications (omitted doses) decreased from 12.0% in the pre-EPAS audit to 3.5% in the post-EPAS audit (p < 0.0001). The number of patients with at least one pharmaceutical review documented in their medication charts was lower in the post-EPAS phase of the study compared with before EPAS implementation (26% vs 38%, respectively; p = 0.0376). Similarly, the percentage of medication orders with a pharmacist's annotation was also lower after EPAS implementation (5.1% vs 19%; p < 0.0001). Documentation of patient weight was threefold more common after EPAS implementation (66% and 21%; p < 0.0001).
DISCUSSION
This is the first comprehensive audit of medication prescribing using the Allscripts electronic health record in Australasia. Using robust NIMC audit methodology, the audit showed substantial improvement in prescribing errors using e-prescribing in EPAS. As expected, the greatest improvements were in prescribing ordering errors due to unclear and illegal prescriptions. Unclear prescriptions take up nursing and pharmacy time in order clarification, and illegal orders (e.g. missing frequency) can result in delayed dosing and additional work for medical staff to rectify. Due to the high prevalence of prescription orders with unclear or missing information, there is good reason to assume that some of these orders would have resulted in medication errors and patient harm. There is evidence that electronic medication management does not affect the amount of time spent on direct care and medication-related tasks.
14 The additional time taken with electronic documentation may be offset by less time taken with the large number of prescription orders that require clarification and correction using paper-based prescribing.
The implementation of EPAS effectively eliminated unsafe prescription orders from 5.8% of prescriptions using the NIMC to 0.03% with EPAS. Based on the number of medicines prescribed per patient, the unsafe prescription rate per patient was reduced from approximately 1 in 2 patients to 1 in 300. This positive effect of e-prescribing is much greater than expected or previously reported. 15, 16 Our audit predominantly captured the elimination of procedural errors. Errors attributed to unclear, incomplete or even unsafe prescriptions that may have been intercepted by nursing or pharmacy staff were unlikely to be captured. The electronic interface may have led to new errors, such as additional duplicate orders, but, as previous data have shown, the reduction in the procedural error rates is much greater than introduction of new system-related errors; hence, the overall error rate is expected to be lower. 17 Although the implementation of e-prescribing resulted in a decrease in the total number of medication errors, most of these errors are seen by users as new or systemrelated errors, hence the perception that the electronic systems themselves are inherently unsafe. 18 The improvements in prescribing were better than other interventions in similar populations. An intervention involving compulsory completion of online prescribing modules and attendance at 10 face-to-face prescribing education sessions for final year medical students resulted in the reduction of unsafe prescriptions from 74.0% to 62.7%. 19, 20 Another educational intervention involving a multifaceted intervention of online education, nurse education and academic detailing of prescribers demonstrated relative improvements of approximately 20%, but 'significant rates of prescribing breaches' persisted.
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The implementation of e-prescribing resulted in effects other than reducing prescribing errors, possibly due to the system alerts. For example, the rate of ADR and weight documentation increased due to alerts prompting this information to be added for patients for whom it was absent. The number of omitted medications was also reduced by two-thirds, possibly due to a red box appearing on the electronic medication administration record when administration was delayed by more than an hour. However, where the documentation required change in workflows (e.g. documentation of pharmaceutical review or pharmacist annotation on medication orders), the rate of appropriate documentation was reduced.
The strengths of the present study include the evaluation of three different hospitals with different settings and a large sample size to allow unequivocal conclusions about the outcomes. The methodology was based on a national approach evaluating prescribing, and the baseline data had been collected in a standard fashion consistently at all sites. The sample was randomly selected and included prescribing in emergency, medical, surgical, rehabilitation and mental health units. We also divided prescribing errors into three categories: unclear prescription orders, illegal prescriptions and unsafe prescriptions. This allowed a clear understanding of the effect of prescribing improvements from lowest to highest impact changes.
There are several study limitations that should be noted. First, this was an audit of prescribing, and although we could impute benefits in medication safety and reduced patient harm, because of study design we did not collect information about outcomes. Second, there was no analysis of system-related errors with EPAS but, as discussed above, these are unlikely to have outweighed the improvements in prescribing. Third, despite the size of the audit, we were unable to look at specific issues that had small numbers, such as warfarin and heparin prescriptions and re-exposure to ADRs causing patient harm. Further audits of high-risk medications, such as anticoagulants, and ADR re-exposure should be the focus of future research. Fourth, the pre-and post-EPAS audits were performed 2 years apart. However, the role of the hospital and staffing of doctors, nurses and pharmacists did not change in the intervening period. The NIMC data had also been stable in the audits prior to 2012. Finally, the audit used the NIMC audit methodology, which is useful for assessment of prescribing errors, but it does not capture other aspects of medication safety.
In conclusion, the introduction of e-prescribing using EPAS resulted in improved prescribing, not just in terms of clarity and completeness of prescription orders, but also a substantial reduction in unsafe prescriptions. Improvements in other areas of medication safety were also likely due to better alerts, such as for ADRs. Although the number of duplicate orders increased, new system-related errors were probably introduced, and changes in workflows resulted in poorer documentation of pharmacist interventions. The combined negative effect of these is unlikely to outweigh the benefits on medication safety from improved prescribing.
